NLRP3 and metabolic disease: A number of exogenous and endogenous signals might act as NLRP3 inflammasome activator in AT leading to the production of pro-inflammatory cytokines [40,41] a potential mechanism linking an elevated intake of saturated fatty acids (SFAs) to the progression of metabolic diseases.